Frankly Speaking About Family Medicine Microhematuria and the Right Time to Refer: Guideline Updates – Frankly Speaking Ep 455
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-455 Overview: Microscopic hematuria is common in primary care, but not every patient needs an urgent...
MDS Podcast Updates in tauopathies • 2025 MDS Congress
Dr. Yaroslau Compta discusses how the view of co-pathologies has changed the view of many disorders, including tauopathies. He dives into the current state of clinical trials for PSP...
MDS Podcast Motor rehabilitation for Parkinson’s disease • 2025 MDS Congress
Rehabilitation for movement disorders, like PD, has become increasingly prevalent for patient care. Prof. Alice Nieuwboer discusses how technology has shaped the field, how neurologists can support patient exercise,...
MDS Podcast Disease modification and Parkinson’s disease: Clinical trial design and population selection • 2025 MDS Congress
There have been nearly 30 years of disease modifying trials for PD, but little success. Prof. Tanya Simuni breaks down clinical trial design for a heterogenous disease like PD...
MDS Podcast Current landscape of pediatric movement disorders • 2025 MDS Congress
Due to genetic advancements, the pediatric movement disorder field is ever growing. Dr. Shekeeb Mohammad breaks down the current landscape of the field and how adult neurologists can advance...
MDS Podcast Current genetic landscape for movement disorders • 2025 MDS Congress
The field of genetics often moves quickly, making it a challenge to stay informed. Dr. Gerard Saranza breaks down the current landscape, new discoveries and technologies, and what changes...
MDS Podcast Achievements and future goals: An interview with MDS President • 2025 MDS Congress
Dr. Victor Fung reflects on his term as MDS President and his appreciation for the accomplishments that were achieved. He further discusses his future hopes and goals of the...
ScienceLink Cobertura ScienceLink Berlín 2025: Highlights día 3
La Dra. Isabel Enríquez, en conjunto con el Dr. DavidJosé Heredia, ambos oncólogos médicos mexicanos, comparten su análisis de losestudios más relevantes presentados durante el tercer día del Congreso Anual...
ScienceLink Avances en el estudio MATTERHORN y nuevas opciones en cáncer escamoso
En esta cápsula de ESMO 2025 EXPRESS, el Dr. Juan Manuel O’Connor, oncólogo médico, jefe de la sección de Tumores Gastrointestinales del Instituto Alexander Fleming en Buenos Aires, Argentina...
ScienceLink Estudios importantes en ESMO 2025 sobre tumores ginecológicos
En esta cápsula de ESMO 2025 EXPRESS, el Dr. Gonzalo Giornelli, oncólogo clínico y jefe del Departamento de Gineco-Oncología del Instituto Alexander Fleming en Buenos Aires, Argentina, nos comenta...
ScienceLink Avances en el ensayo ALEX y estudios en cáncer de pulmón de células pequeñas
En esta cápsula de ESMO 2025 EXPRESS, el Dr. Luis Corrales, oncólogo médico adscrito al Centro de Investigación y Manejodel Cáncer en San José, Costa Rica, nos habló sobre...